Literature DB >> 12613384

Revisiting ethical guidelines for research with terminal wean and brain-dead participants.

Rebecca D Pentz, Anne L Flamm, Renata Pasqualini, Christopher J Logothetis, Wadih Arap.   

Abstract

Some research is too risky to be conducted on anyone with a life expectancy of more than a few hours. Yet under some circumstances, the research can still be carried out by using subjects who are either brain dead or are soon to undergo a terminal wean, and who have articulated values that inclusion in the study can honor. So argues a team of ethicists and researchers at M.D. Anderson Cancer Center, where such research was recently undertaken.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2003        PMID: 12613384

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  10 in total

1.  Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis.

Authors:  Emmanuel Dias-Neto; Diana N Nunes; Ricardo J Giordano; Jessica Sun; Gregory H Botz; Kuan Yang; João C Setubal; Renata Pasqualini; Wadih Arap
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

2.  Stakeholder perceptions of thoracic rapid tissue donation: An exploratory study.

Authors:  Jessica McIntyre; Christie Pratt; Rebecca D Pentz; Eric B Haura; Gwendolyn P Quinn
Journal:  Soc Sci Med       Date:  2013-09-06       Impact factor: 4.634

3.  Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.

Authors:  Fernanda I Staquicini; Marina Cardó-Vila; Mikhail G Kolonin; Martin Trepel; Julianna K Edwards; Diana N Nunes; Anna Sergeeva; Eleni Efstathiou; Jessica Sun; Nalvo F Almeida; Shi-Ming Tu; Gregory H Botz; Michael J Wallace; David J O'Connell; Stan Krajewski; Jeffrey E Gershenwald; Jeffrey J Molldrem; Anne L Flamm; Erkki Koivunen; Rebecca D Pentz; Emmanuel Dias-Neto; João C Setubal; Dolores J Cahill; Patricia Troncoso; Kim-Ahn Do; Christopher J Logothetis; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-02       Impact factor: 11.205

4.  Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.

Authors:  Katja Karjalainen; Diana E Jaalouk; Carlos Bueso-Ramos; Laura Bover; Yan Sun; Akihiko Kuniyasu; Wouter H P Driessen; Marina Cardó-Vila; Cecilia Rietz; Amado J Zurita; Susan O'Brien; Hagop M Kantarjian; Jorge E Cortes; George A Calin; Erkki Koivunen; Wadih Arap; Renata Pasqualini
Journal:  Clin Cancer Res       Date:  2015-03-16       Impact factor: 12.531

Review 5.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

6.  Quality-of-life considerations in substitute decision-making for severely disabled neonates: the problem of developing awareness.

Authors:  Eike-Henner W Kluge
Journal:  Theor Med Bioeth       Date:  2009

Review 7.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

8.  Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study.

Authors:  Renata Pasqualini; Randall E Millikan; Dawn R Christianson; Marina Cardó-Vila; Wouter H P Driessen; Ricardo J Giordano; Amin Hajitou; Anh G Hoang; Sijin Wen; Kirstin F Barnhart; Wallace B Baze; Valerie D Marcott; David H Hawke; Kim-Anh Do; Nora M Navone; Eleni Efstathiou; Patricia Troncoso; Roy R Lobb; Christopher J Logothetis; Wadih Arap
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

Review 9.  Vascular targeting: recent advances and therapeutic perspectives.

Authors:  Amin Hajitou; Renata Pasqualini; Wadih Arap
Journal:  Trends Cardiovasc Med       Date:  2006-04       Impact factor: 6.677

10.  A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.

Authors:  Marina Cardó-Vila; Amado J Zurita; Ricardo J Giordano; Jessica Sun; Roberto Rangel; Liliana Guzman-Rojas; Cristiane D Anobom; Ana P Valente; Fábio C L Almeida; Johanna Lahdenranta; Mikhail G Kolonin; Wadih Arap; Renata Pasqualini
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.